Search research articles
Contact Us
Filters
Showing results (271-280 of 315) with videos related to
Page
of 32
Sort By:
Cancer Research
|
May 20, 2016
Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells
Roberta Ferraldeschi, Jonathan Welti, Marissa V Powers, et al.
Scientific Reports
|
October 7, 2016
A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoforms
Alan M Jones, Isaac M Westwood, James D Osborne, et al.
Cancer Research
|
March 3, 2007
In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitors
Swee Y Sharp, Kathy Boxall, Martin Rowlands, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2009
EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines
Dorine A Bax, Nathalie Gaspar, Suzanne E Little, et al.
ACS Chemical Biology
|
July 2, 2025
Mediator Kinase Inhibitor Selectivity and Activity in Colorectal Cancer
Maria J Ortiz-Ruiz, Olajumoke Popoola, Konstantinos Mitsopoulos, et al.
Oncotarget
|
September 28, 2013
The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design
Sylvain Couty, Isaac M Westwood, Andrew Kalusa, et al.
Molecular Cancer Therapeutics
|
December 31, 2010
Preclinical pharmacology, antitumor activity, and development of pharmacodynamic markers for the novel, potent AKT inhibitor CCT128930
Timothy A Yap, Mike I Walton, Lisa-Jane K Hunter, et al.
Cancer Research
|
January 4, 2019
Correction: <i>In vitro</i> Biological Characterization of a Novel, Synthetic Diaryl Pyrazole Resorcinol Class of Heat Shock Protein 90 Inhibitors
Swee Y Sharp, Kathy Boxall, Martin Rowlands, et al.
Journal of Medicinal Chemistry
|
June 23, 2010
Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases: lead optimization studies toward the identification of an orally bioavailable preclinical development candidate
Vassilios Bavetsias, Jonathan M Large, Chongbo Sun, et al.
Journal of Medicinal Chemistry
|
January 12, 2026
Unhooking the Hook: Optimization of the Aurora A Targeting PROTAC <b>JB170</b> to <b>CCT400028</b>, an <i>In Vitro</i> Degrader Chemical Probe
Jack A O'Hanlon, Katrin Gutsche, Juliane Elisabeth Müller, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 315) with videos related to
Sort By:
Page
of 32
Cancer Research
|
May 20, 2016
Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells
Roberta Ferraldeschi, Jonathan Welti, Marissa V Powers, et al.
Scientific Reports
|
October 7, 2016
A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoforms
Alan M Jones, Isaac M Westwood, James D Osborne, et al.
Cancer Research
|
March 3, 2007
In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitors
Swee Y Sharp, Kathy Boxall, Martin Rowlands, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2009
EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines
Dorine A Bax, Nathalie Gaspar, Suzanne E Little, et al.
ACS Chemical Biology
|
July 2, 2025
Mediator Kinase Inhibitor Selectivity and Activity in Colorectal Cancer
Maria J Ortiz-Ruiz, Olajumoke Popoola, Konstantinos Mitsopoulos, et al.
Oncotarget
|
September 28, 2013
The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design
Sylvain Couty, Isaac M Westwood, Andrew Kalusa, et al.
Molecular Cancer Therapeutics
|
December 31, 2010
Preclinical pharmacology, antitumor activity, and development of pharmacodynamic markers for the novel, potent AKT inhibitor CCT128930
Timothy A Yap, Mike I Walton, Lisa-Jane K Hunter, et al.
Cancer Research
|
January 4, 2019
Correction: <i>In vitro</i> Biological Characterization of a Novel, Synthetic Diaryl Pyrazole Resorcinol Class of Heat Shock Protein 90 Inhibitors
Swee Y Sharp, Kathy Boxall, Martin Rowlands, et al.
Journal of Medicinal Chemistry
|
June 23, 2010
Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases: lead optimization studies toward the identification of an orally bioavailable preclinical development candidate
Vassilios Bavetsias, Jonathan M Large, Chongbo Sun, et al.
Journal of Medicinal Chemistry
|
January 12, 2026
Unhooking the Hook: Optimization of the Aurora A Targeting PROTAC <b>JB170</b> to <b>CCT400028</b>, an <i>In Vitro</i> Degrader Chemical Probe
Jack A O'Hanlon, Katrin Gutsche, Juliane Elisabeth Müller, et al.
Page
of 32